Bulletin
Investor Alert

New York Markets Close in:

Stocks

Here are your odds that stock prices will be higher at the end of 2021

U.S. stocks rise in three out of every four years, especially the first year of a presidential term. 12:54 p.m. Today

Beware of ‘zombie’ companies running rampant in the stock market

A total of 19%, or 571 companies, in the Russell 3000 Index are considered unviable, writes William Barritt. 12:48 p.m. Today

Dow ends more than 300 points higher on vaccine progress

Stocks closed with solid gains Monday, boosted by another round of positive news regarding the development of COVID-19 vaccines, while extending gains late in the session after The Wall Street Journal reported that President-elect Joe Biden would nominate former Federal Reserve Chair Janet Yellen to serve as Treasury secretary in his administration. The Dow Jones Industrial Average rose around 330 points, or 1.1%, to end near 29,594, according to preliminary figures, while the S&P 500 finished up around 20 points, or 0.6%, near 3,578. The Nasdaq Composite rose around 26 points, or 0.2%, ending the session near 12,424. AstraZeneca on Monday said its vaccine candidate had an efficacy rate of up to 90% in late-stage trials, following positive news earlier this month regarding a vaccine candidate developed by Pfizer Inc. and BioNTech and another developed by Moderna Inc. 4:02 p.m. Nov. 23, 2020

Stocks Headlines

 - skynesher/iStock
Another bullish factor for the S&P 500: strong seasonal trends come with Thanksgiving turkey

Maintain a bullish stance unless the S&P 500 closes below 3,500.

8:28 a.m. Nov. 23, 2020
 - Getty Images
Active managers see value in these 3 company practices but indexers hate them. Who’s right?

Savvy investors see value in combining CEO and chairman role; staggered director terms and dual share classes, writes Lawrence A. Cunningham.

4:03 p.m. Nov. 21, 2020
 - Getty Images
The Dow has completely recovered its 2020 bear-market loss. Here’s what comes next

Dow’s recovery since March is impressive but says nothing about how long the bull market will run, writes Mark Hulbert.

10:24 a.m. Nov. 21, 2020
 - Getty Images
Absurdly expensive stocks — like those today — rarely become global leaders, history shows

The more expensive the stock, the bigger the relative underperformance, reports Daniel Taylor at asset manager Man Numeric.

7:33 a.m. Nov. 20, 2020
Stocks pull back from records to end lower as economic worries rise

Stocks ended lower Tuesday after data confirmed a slowdown in retail sales last month and COVID-19 cases continued to rise. The pullback came a day after the Dow Jones Industrial Average and S&P 500 closed at records, in a rally propelled by continued progress toward a vaccine. The Dow on Tuesday fell around 166 points, or 0.6%, to finish near 29,784, according to preliminary figures, while the S&P 500 lost around 17 points, or 0.5%, to close near 3,610. The tech-heavy Nasdaq Composite , which was left behind in the vaccine-inspired rally as investors rotated into economically sensitive stocks that have been left behind during the pandemic, fell around 25 points, or 0.2%, closing near 11,899. October retail sales fell 0.3%, in line with expectations but the smallest rise in six months.

4:03 p.m. Nov. 17, 2020
 - Getty Images
The S&P 500 is on the verge of ‘upside confirmation’

A close above 3,588 points in the benchmark index would be a breakout and could have follow-through.

11:41 a.m. Nov. 16, 2020
S&P 500 ends at record as stocks rally amid vaccine hopes

Stocks scored gains Friday, with the S&P 500 closing at a record as investors cheered progress toward a COVID-19 vaccine, while seeming to look past a continued rise in new cases of the ilness. The Dow Jones Industrial Average rose around 399 points, or 1.4%, to close near 29,480, according to preliminary figures, while the S&P 500 gained around 48 points, or 1.4%, to finish near 3,585, topping its previous record close of 29,551.42 from Sept. 2. The Nasdaq Composite rose around 120 points, or 1%, to finish near 11,829. Stocks were on the rise this week after Pfizer Inc. and BioNTech SE on Monday announced their COVID-19 vaccine candidate was more than 90% effective in preventing the disease in a trial. The news sparked a rotation away from high-flying tech and internet shares that were seen as beneficiaries of the pandemic into cyclical and small-cap shares that were left behind by 2020's stock-market gains. The tech-heavy Nasdaq saw weekly fall of 0.6%, while the more cyclically oriented Dow rose 4.1%. The S&P 500 saw a gain of 2.2%. The Russell 2000, meanwhile, rose around 2.1%.

4:11 p.m. Nov. 13, 2020
 - JIM WATSON/AFP via Getty Images
Why value stocks could rally in the Biden administration’s first 100 days

Value historically has performed best after new presidents take office.

3:24 p.m. Nov. 13, 2020

Video

Here's how the pandemic is impacting the future of work

  • Here's how the pandemic is impacting the future of work Here's how the pandemic is impacting the future of work 3:02
    FIRE helped this flight attendant take a break from work amid COVID-19 FIRE helped this flight attendant take a break from work amid COVID-19 4:30
    How to pick winners in the retail sector amid the pandemic How to pick winners in the retail sector amid the pandemic 3:59
    Should I rent or own property? Should I rent or own property? 1:43
  • Amid the pandemic parents turn to 'microschools': Here's what they are Amid the pandemic parents turn to 'microschools': Here's what they are 3:34
    What happens if my debt goes to a collection agency? What happens if my debt goes to a collection agency? 1:47
    What a V or a K-shaped recovery looks like - and what it means for you What a V or a K-shaped recovery looks like - and what it means for you 2:39
    3 sectors to watch beyond the election 3 sectors to watch beyond the election 3:37
  • This blogger found FIRE and built a six-figure net worth in her 20s This blogger found FIRE and built a six-figure net worth in her 20s 6:51
    What you need to know about new U.S. crude oil price benchmarks What you need to know about new U.S. crude oil price benchmarks 3:24
Link to MarketWatch's Slice.